# Oxybutynin

## Oxbu 5mg extended-release

| TAH Drug Code      | [OOXB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OOXB                                                           |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of symptoms associated w/ voiding in patients w/ uninhibited neurogenic & reflex neurogenic bladder.                   |
| Dosing             | Initially, 5 mg once daily increased by 5 mg every week if necessary to the maximum 30 mg daily.                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                 |
| Contraindications  | Myasthenia gravis, glaucoma; GI obstruction, paralytic ileus, intestinal atony, megacolon, severe colitis; acute haemorrhage. |
| Adverse Effects    | Dry mouth, blurred vision, tachycardia, dizziness, impotence; allergic reactions.                                             |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/oxybutynin-drug-information)                                                     |

